Miljöpåverkan
Miljöinformationen för buprenorfin är framtagen av företaget Camurus för Buvidal
Miljörisk:
Risk för miljöpåverkan av buprenorfin kan inte uteslutas då det inte finns tillräckliga ekotoxikologiska data.
Nedbrytning:
Det kan inte uteslutas att buprenorfin är persistent, då data saknas.
Bioackumulering:
Buprenorfin har låg potential att bioackumuleras.
Läs mer
Detaljerad miljöinformation
Environmental Risk Classification
Predicted Environmental Concentration (PEC)
PEC is calculated according to the following formula:
PEC (μg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6 *47.31*(100-0)
Where:
A = 47.31 kg (total sold amount buprenorphine and buprenorphine hydrochloride in Sweden year 2022, data from IQVIA).
R = % removal rate (due to loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation) = 0 if no data is available. (If R is not equal to 0 this should be justified under the degradation section)
P = number of inhabitants in Sweden = 10 *106
V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Ref. I)
D = factor for dilution of waste water by surface water flow = 10 (ECHA default) (Ref. I)
PEC = 0.0064 μg/L
According to the European Medicines Agency guideline on environmental risk assessment of medicinal products (EMA/CHMP/SWP/4447/00), use of buprenorphine is unlikely to represent a risk for the environment, because the predicted environmental concentration (PEC) at the time of registration was below the action limit 0.01 µg/L.
Predicted No Effect Concentration (PNEC)
No data available
Environmental risk classification (PEC/PNEC ratio)
No data available.
Degradation
No data available.
Bioaccumulation
Partitioning coefficient: Log Dow = 3.7 at pH 7 (guideline OECD 107). (Ref II)
Justification of chosen bioaccumulation phrase: Since log Dow < 4 at pH 7, the substance has low potential for bioaccumulation.
Excretion (metabolism)
Buprenorphine is oxidatively metabolised by 14-N-dealkylation to N-desalkyl-buprenorphine (also known as norbuprenorphine) via cytochrome P450 CYP3A4 and by glucuroconjungation of the parent molecule and the dealkylated metabolite. Norbuprenorphine is a µ-opioid agonist with weak intrinsic activity.
As the main metabolite is pharmacologically active, no reduction of A in the PEC calculation has been made.
References
I. ECHA, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment. http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_en.htm
II. Volic, N., 2020. Determination of physico-chemical properties of Buprenorphine: partition coefficient at pH5 and pH7 using shake flask method; partion coefficient at pH 9 using slow-stirring method. Charles River Laboratories Den Bosch, Study No. 20186155
Miljöinformationen för naloxon är framtagen av företaget DNE Pharma för Respinal
Miljörisk:
Risk för miljöpåverkan av naloxon kan inte uteslutas då det inte finns tillräckliga ekotoxikologiska data.
Nedbrytning:
Naloxon är potentiellt persistent.
Bioackumulering:
Naloxon har låg potential att bioackumuleras.
Läs mer
Detaljerad miljöinformation
Environmental Risk Classification
Predicted Environmental Concentration (PEC)
PEC is calculated according to the following formula:
PEC (µg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6*A*(100-R)
PEC = 0.0076 μg/L
Where:
A = 55.495 kg = (total sold amount API in Sweden year 2022, data from IQVIA).
R = 0 % removal rate (due to loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation) = 0 if no data is available.
P = number of inhabitants in Sweden = 10*106
V (L/day) = volume of wastewater per capita and day = 200 (ECHA default)
(Ref. I)
D = factor for dilution of waste water by surface water flow = 10 (ECHA default)
(Ref. I)
PEC calculation for naloxone
A = 55.495 kg (addition of 55.4946 kg (naloxone hydrochloride dihydrate) and 0.00015 kg (naloxone hydrochloride, anhydrous))
PEC (µg/L) = 1.37*10-4*A = 0.0076 μg/L
Predicted No Effect Concentration (PNEC)
Ecotoxicological studies
Algae (Pseudokirchneriella subcapitata)
EC50 72 hours (growth rate) = 51.2 mg/L = 51 200 μg/L
NOEC 72 hours (growth rate) = 2.67 mg/L = 2670 μg/L
Guideline: OECD 201 (Growth Inhibition Test)
(Ref. II)
Crustacean (Daphnia sp.)
EC50 48 hours (mobility) > 100 mg/L = 100 000 μg/L
Guideline: OECD 202 (Acute Immobilisation Test)
(Ref. III)
Fish: No data available.
Other ecotoxicity data:
PNEC: No PNEC can be calculated since there is not sufficient ecotoxicity data available.
Environmental Risk Classification (PEC/PNEC ratio)
Risk of environmental impact of naloxone cannot be excluded since there is not sufficient data available to calculate a PEC/PNEC ratio.
According to the European Medicines Agency guideline on environmental risk assessment of medicinal products (EMA/CHMP/SWP/4447/00), use of naloxone is unlikely to represent a risk for the environment, because the predicted environmental concentration (PEC) is below the action limit 0.01 µg/L.
Degradation
Biotic degradation
Ready degradability:
The degradation rate of naloxone was 0 % after 28 days.
Guideline: OECD 301 F (Ready Biodegradability: Manometric Respirometry Test)
Naloxone is considered to be not readily biodegradable.
(Ref. IV)
Justification of chosen degradation phrase:
Naloxone is potentially persistent.
Bioaccumulation
Partitioning coefficient:
log Kow: 2.09 (method and pH not found)
(Ref. V)
Justification of chosen bioaccumulation phrase:
Since log Kow < 4, naloxone has low potential for bioaccumulation.
Excretion (metabolism)
Naloxone is metabolized in the liver, primarily by glucuronide conjugation, with naloxone-3-glucoronide as the major metabolite.
(Ref. VI)
References
-
ECHA – Naloxone Toxicity to aquatic algae and cyanobacteria, retrieved 2024-02-14 from ECHA website.
-
ECHA – Naloxone Short-term toxicity to aquatic invertebrates, retrieved 2024-02-14 from ECHA website.
-
ECHA – Naloxone Biodegradation in water: screening tests, retrieved 2024-02-14 from ECHA website.
-
PubChem – Naloxone, retrieved 2024-02-14 from PubChem webpage.
-
Respinal SmPC, retrieved 2024-02-14 from MPA webpage.